KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 83 filers reported holding KRONOS BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,147 | -49.8% | 3,029 | +8.3% | 0.00% | -100.0% |
| Q1 2022 | $20,215 | -87.4% | 2,796 | -76.4% | 0.00% | -50.0% |
| Q4 2021 | $161,055 | -35.2% | 11,851 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $248,397 | -12.5% | 11,851 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $283,831 | +125.6% | 11,851 | +175.7% | 0.00% | +100.0% |
| Q1 2021 | $125,832 | -12.6% | 4,299 | -10.8% | 0.00% | 0.0% |
| Q4 2020 | $143,944 | – | 4,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $80,941,000 | 20.45% |
| Omega Fund Management, LLC | 3,818,283 | $111,761,000 | 10.57% |
| Wildcat Capital Management, LLC | 1,438,232 | $42,097,000 | 5.14% |
| COMMODORE CAPITAL LP | 298,839 | $8,747,000 | 3.48% |
| Alphabet Inc. | 1,438,232 | $42,097,000 | 1.70% |
| Octagon Capital Advisors LP | 146,173 | $4,278,000 | 1.61% |
| Perceptive Advisors | 2,780,097 | $79,671,000 | 1.01% |
| DSAM Partners (London) Ltd | 177,426 | $5,193,000 | 0.96% |
| Samsara BioCapital, LLC | 166,250 | $4,866,000 | 0.90% |
| Artal Group S.A. | 1,317,954 | $38,577,000 | 0.68% |